Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionglycerol-3-phosphate O-acyltransferase activity

GPAT3 GPAT4

2.97e-055352GO:0004366
GeneOntologyMolecularFunctionsemaphorin receptor activity

PLXND1 PLXNB2

1.95e-0412352GO:0017154
GeneOntologyMolecularFunction1-acylglycerol-3-phosphate O-acyltransferase activity

GPAT3 GPAT4

6.14e-0421352GO:0003841
GeneOntologyMolecularFunctionlysophosphatidic acid acyltransferase activity

GPAT3 GPAT4

8.04e-0424352GO:0042171
GeneOntologyMolecularFunctionlysophospholipid acyltransferase activity

GPAT3 GPAT4

8.04e-0424352GO:0071617
GeneOntologyMolecularFunctionacylglycerol O-acyltransferase activity

GPAT3 GPAT4

1.43e-0332352GO:0016411
GeneOntologyCellularComponentsemaphorin receptor complex

PLXND1 PLXNB2

2.10e-0413352GO:0002116
MousePhenoabnormal skin adnexa physiology

PLXND1 GK5 LYST GPAT4 LEPR

5.12e-06167225MP:0010680
DomainPlexin_cytopl

PLXND1 PLXNB2

1.08e-049332PF08337
DomainPlexin_cytoplasmic_RasGAP_dom

PLXND1 PLXNB2

1.08e-049332IPR013548
DomainPlexin

PLXND1 PLXNB2

1.08e-049332IPR031148
DomainAcyltransferase

GPAT3 GPAT4

3.58e-0416332PF01553
DomainPlsC

GPAT3 GPAT4

4.05e-0417332SM00563
DomainPlipid/glycerol_acylTrfase

GPAT3 GPAT4

4.05e-0417332IPR002123
DomainIg_E-set

PLXND1 PLXNB2 KCNJ4

8.10e-04104333IPR014756
DomainIPT

PLXND1 PLXNB2

1.03e-0327332SM00429
DomainTIG

PLXND1 PLXNB2

1.36e-0331332PF01833
DomainSEMA

PLXND1 PLXNB2

1.36e-0331332PS51004
DomainSema

PLXND1 PLXNB2

1.36e-0331332SM00630
DomainSemap_dom

PLXND1 PLXNB2

1.36e-0331332IPR001627
DomainSema

PLXND1 PLXNB2

1.36e-0331332PF01403
DomainPlexin_repeat

PLXND1 PLXNB2

1.45e-0332332IPR002165
DomainPSI

PLXND1 PLXNB2

1.45e-0332332PF01437
DomainIPT

PLXND1 PLXNB2

1.45e-0332332IPR002909
Domain-

PLXND1 PLXNB2 LYST EML6

2.70e-033333342.130.10.10
DomainPSI

PLXND1 PLXNB2

2.73e-0344332IPR016201
DomainWD40/YVTN_repeat-like_dom

PLXND1 PLXNB2 LYST EML6

2.76e-03335334IPR015943
DomainPSI

PLXND1 PLXNB2

2.98e-0346332SM00423
DomainDH_1

OBSCN PLEKHG3

5.53e-0363332PS00741
DomainRhoGEF

OBSCN PLEKHG3

6.41e-0368332SM00325
DomainPH_dom-like

OBSCN SSRP1 LYST PLEKHG3

6.47e-03426334IPR011993
DomainDH_2

OBSCN PLEKHG3

6.78e-0370332PS50010
DomainRhoGEF

OBSCN PLEKHG3

6.78e-0370332PF00621
DomainDH-domain

OBSCN PLEKHG3

6.97e-0371332IPR000219
Domain-

OBSCN PLEKHG3

6.97e-03713321.20.900.10
Domain-

MDN1 SVEP1

7.55e-03743323.40.50.410
DomainVWFA

MDN1 SVEP1

9.20e-0382332PS50234
DomainVWA

MDN1 SVEP1

9.64e-0384332SM00327
DomainRho_GTPase_activation_prot

PLXND1 PLXNB2

1.05e-0288332IPR008936
Pubmed

Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production.

PLXND1 PLXNB2

9.84e-07235222916243
Pubmed

Glycerol-3-phosphate acyltransferases 3 and 4 direct glycerolipid synthesis and affect functionality in activated macrophages.

GPAT3 GPAT4

9.84e-07235230523059
Pubmed

Triacylglycerol synthesis directed by glycerol-3-phosphate acyltransferases -3 and -4 is required for lipid droplet formation and the modulation of the inflammatory response during macrophage to foam cell transition.

GPAT3 GPAT4

9.84e-07235233260006
Pubmed

GPAT3 and GPAT4 are regulated by insulin-stimulated phosphorylation and play distinct roles in adipogenesis.

GPAT3 GPAT4

9.84e-07235220181984
Pubmed

Mechanical deformation of ventricular myocytes modulates both TRPC6 and Kir2.3 channels.

KCNJ4 TRPC6

9.84e-07235218635261
Pubmed

Insulin-activated store-operated Ca2+ entry via Orai1 induces podocyte actin remodeling and causes proteinuria.

LEPR TRPC6

2.95e-06335234764278
Pubmed

SEIPIN Regulates Lipid Droplet Expansion and Adipocyte Development by Modulating the Activity of Glycerol-3-phosphate Acyltransferase.

GPAT3 GPAT4

2.95e-06335227806294
Pubmed

Transcriptome analysis of mouse stem cells and early embryos.

GPAT3 IPO5 MDN1 ZGRF1 LEPR

3.02e-0536335514691545
Pubmed

Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina.

PLXND1 PLXNB2

6.45e-051235221270798
Pubmed

Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates.

PLXND1 PLXNB2

7.62e-051335210520995
Pubmed

Mutations in mice that influence natural killer (NK) cell activity.

LYST LEPR

8.89e-05143526971254
Pubmed

Genetic dissection of plexin signaling in vivo.

PLXND1 PLXNB2

1.02e-041535224469813
Pubmed

Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections.

PLXND1 PLXNB2

1.33e-041735211683995
Pubmed

Semaphorin signaling facilitates cleft formation in the developing salivary gland.

PLXND1 PLXNB2

1.33e-041735217626059
Pubmed

Genome-wide association study for refractive astigmatism reveals genetic co-determination with spherical equivalent refractive error: the CREAM consortium.

LVRN EML6

1.66e-041935225367360
Pubmed

Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex.

IPO5 MDN1 SSRP1

1.68e-0410635319394292
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

IPO5 SCAMP3 MDN1 SSRP1 PLXNB2 PLEKHG3

5.02e-04102435624711643
Pubmed

Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.

GPAT3 MDN1 PLXNB2 GPAT4

5.35e-0437535432788342
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

OBSCN PLXND1 MDN1 PLXNB2 LYST GPAT4

7.48e-04110535635748872
GeneFamilyGlycerol-3-phosphate acyltransferases

GPAT3 GPAT4

1.59e-0543021035
GeneFamilyPlexins

PLXND1 PLXNB2

9.51e-059302683
GeneFamily1-acylglycerol-3-phosphate O-acyltransferases

GPAT3 GPAT4

1.45e-041130246
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

OBSCN PLEKHG3

5.34e-0366302722
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LVRN LEPR SVEP1 AOX1

9.84e-06172354e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCellCOVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations)

LVRN LEPR SVEP1 AOX1

1.31e-05185354a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LVRN LEPR SVEP1 AOX1

1.40e-05188354e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LVRN LEPR SVEP1 AOX1

1.43e-05189354d531399749409d614adca13d181830c6e3287508
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor

LVRN LEPR SVEP1 AOX1

1.52e-05192354d21f0f577156f17c899b08871046a26b88aea011
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LVRN LEPR SVEP1 AOX1

1.61e-05195354f54bc4454270ff06e85596f98199372b50d0179f
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC9A9 LEPR SVEP1 TRPC6

1.68e-0519735444673c38384453207871d3fd8e8ba9093cc06bc5
ToppCellTracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC9A9 LEPR SVEP1 AOX1

1.78e-05200354b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC9A9 SVEP1 TRPC6 AOX1

1.78e-05200354cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC9A9 LEPR SVEP1 AOX1

1.78e-0520035474e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC9A9 LEPR SVEP1 AOX1

1.78e-052003540c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCellPND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass

OBSCN SLC9A9 TRPC6

1.61e-0413535335928195cf34f055b353562c96f451aef2344d64
ToppCellPND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass

OBSCN LEPR TRPC6

2.29e-04152353fc9472bc19f997103da535b035105f01429cb08e
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSPAN6 KLHL1 AOX1

3.17e-0417035317bd7fd25a2657cb536ad47e294332920f759e95
ToppCell3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue

GK5 LYST PLEKHG3

3.28e-04172353701de463f85aaad3a4b36a0d5fbc416406620089
ToppCellTCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9

LVRN LEPR SVEP1

3.40e-041743530f3ec0d0d4344e10c9b48adc9174123f6402dc51
ToppCellTCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9

LVRN LEPR SVEP1

3.40e-041743537f8f5fafae08676d2b90cab9802c3c9320f1370e
ToppCellTCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9

LVRN LEPR SVEP1

3.40e-04174353e2f240d60bffbe8e6d60f0bb405b231bd3c96875
ToppCellTCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9

LVRN LEPR SVEP1

3.40e-041743531aadbf2642b6d1320ceabd92e6ff59e11f16c315
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CFAP54 KLHL1 EML6

3.45e-04175353284fdc7a9d303636a637041846850d19d114861a
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ZGRF1 LEPR TRPC6

3.45e-041753533e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

LEPR SVEP1 AOX1

3.51e-04176353510f9a14dc1c151d24d079e0cc004cdf4f86336c
ToppCell343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells)

LEPR SVEP1 AOX1

3.51e-041763532e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCellnormal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass

CFAP54 PLXNB2 LEPR

3.51e-041763537a74217b7fa1032b918f00a3972dff5fab74671a
ToppCell343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells)

LEPR SVEP1 AOX1

3.51e-04176353f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCellBAL-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters

GPAT3 TRPC6 EDDM13

3.57e-04177353939487a05311b66edfc3f44a7955fbf25266d6bf
ToppCellE17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

OBSCN TSPAN6 KLHL1

3.63e-041783530139b42494c1186390b12106dea7957e2b6717c2
ToppCell356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells)

LEPR SVEP1 AOX1

3.63e-04178353a493a277d175e5e153410a745b26ebe2e0839ea0
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLXND1 EDDM13 OR2AG1

3.63e-04178353462111b61f37338f97ac7dc6c7da1d4316b54445
ToppCell356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells)

LEPR SVEP1 AOX1

3.63e-04178353371218babddfd3d8a7bb82a46ce65327ee3fcf12
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DCAF15 PLXND1 LYST

3.63e-041783530290868dc990878eac5c182fe64968333bc52450
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLXND1 LYST LEPR

3.87e-04182353d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCellAdult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor

OBSCN PLEKHG3 TRPC6

3.94e-04183353fc31a43a637423cb3bb9aa184a3a889a0b9aaea6
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GPAT3 TRPC6 EDDM13

4.00e-04184353a45980306c4e697a2703bed72a7b48fb23d942f4
ToppCellControl-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class

TSPAN6 GPAT3 SLC9A9

4.00e-04184353b5c1f57f0356969cfb0e1dac764684fc5583bc04
ToppCellBAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GPAT3 TRPC6 EDDM13

4.00e-041843531c56378b3888c46258d446b47de4d6282fe74b0d
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor

LEPR SVEP1 AOX1

4.06e-04185353fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCellfacs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBR1 PLEKHG3 TRPC6

4.13e-04186353e2ba9f3518d87a44537a57a648df17ab98fbbb39
ToppCellfacs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

UBR1 PLEKHG3 TRPC6

4.13e-04186353fda3415222f688ef5cd8de4b0b79daa2493c585f
ToppCellmetastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass

TSPAN6 GPAT3 LEPR

4.13e-041863536259f0f2d5bc863782d09a901d6be2f387d1f074
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LVRN SVEP1 AOX1

4.13e-041863537582b5154d8e5a4434817b5ab77a10b789ea2288
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LEPR SVEP1 AOX1

4.13e-0418635307d94d5d1c2fe7bb909a07ca81058a0eabc65c60
ToppCellAdult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor

OBSCN PLEKHG3 TRPC6

4.19e-0418735362759efb660179402fb574ce5701c89a2e17bcfe
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

SLC9A9 SVEP1 TRPC6

4.19e-04187353a9316e2818217ec5feae9cf8816f7249803caee6
ToppCellControl-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations)

LEPR SVEP1 AOX1

4.26e-04188353706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCellControl-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

GPAT3 SLC9A9 GK5

4.26e-0418835347126c371a242c937499fd278a74a882df8f759c
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.33e-04189353a153b83314cf52808f685296cff8c95af3f4983d
ToppCellfacs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LVRN LEPR SVEP1

4.33e-0418935329287525120be2953b76881ba3cfc4379c265e7a
ToppCellfacs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LVRN LEPR SVEP1

4.33e-041893537150dad9a92a715487c2d8130fa01b752ea69663
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.33e-041893532a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCellfacs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LVRN LEPR SVEP1

4.33e-041893536e4c0effd5192fd00052abc048fdb87a74fb6554
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CFAP54 KLHL1 LEPR

4.33e-04189353bd91bdfe35294e60d980259b70fe9e60dca2743f
ToppCellP03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SLC9A9 LEPR TRPC6

4.39e-04190353979b1476fd2692fde977ce56257315fcfc8a01d5
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor

LVRN SVEP1 AOX1

4.39e-041903537dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC9A9 LEPR TRPC6

4.39e-041903531004e89d99c9d46c78b7d3532d8d4aadb81a96fd
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SLC9A9 LEPR TRPC6

4.39e-0419035310b02c62e72bfea9767e3e751011436925da823e
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.39e-04190353841cd55861b43578d704418b9bc0af2e8b88323a
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

TSPAN6 SVEP1 AOX1

4.39e-04190353d60395739458d7f47a3350ade751fe3819500320
ToppCellP07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SLC9A9 LEPR TRPC6

4.46e-04191353ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.46e-04191353b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellRV-01._Fibroblast_I|World / Chamber and Cluster_Paper

SLC9A9 SVEP1 AOX1

4.46e-0419135370c067c54084bfb02c29bab085f4defd477194fb
ToppCellP07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SLC9A9 LEPR TRPC6

4.46e-041913532ad717b59215ad8d933e9637d363b65d7298e5d4
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SVEP1 TRPC6 AOX1

4.46e-041913536688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SVEP1 TRPC6 AOX1

4.53e-0419235399ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.53e-04192353dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.53e-041923536f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

GPAT3 PLXNB2 GPAT4

4.53e-04192353af453a179f3fdd4ae870f1d98a485e8c9fd726ac
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

GPAT3 PLXNB2 GPAT4

4.53e-04192353176b9c1dd2c91bca46e12fa5060bfe590dc18246
ToppCellP03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SLC9A9 LEPR TRPC6

4.53e-04192353063e119c4b58957643908f667e6cfd6f7517fd03
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.53e-041923533d0cb19f037f604253d7d728689aeaa94251e92b
ToppCellMatrixFB-Fibroblast-D_(Pericyte)|MatrixFB / shred on cell class and cell subclass (v4)

SLC9A9 PLEKHG3 TRPC6

4.53e-04192353630444302511f511ec6976bc045a3b4b9d8d4547
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

GPAT3 PLXNB2 GPAT4

4.53e-0419235381f93b4c853f176c91b5ddef34238e37047a0e69
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LEPR SVEP1 AOX1

4.53e-04192353c5f8e766453f87847b740d6988c524b3d0ef3765
ToppCellControl-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class

GPAT3 SLC9A9 GK5

4.53e-04192353ad04c9c4bdebf94615cee1904ca48197e62c923b
ToppCellRV-01._Fibroblast_I|RV / Chamber and Cluster_Paper

SLC9A9 SVEP1 AOX1

4.53e-04192353356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.60e-04193353fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellLA|World / Chamber and Cluster_Paper

LVRN SLC9A9 SVEP1

4.60e-04193353d4bf89437216baf489ea0239136dcedf3b6714af
ToppCellLV-01._Fibroblast_I|LV / Chamber and Cluster_Paper

SLC9A9 SVEP1 AOX1

4.60e-04193353dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLXND1 LYST LEPR

4.60e-04193353c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.67e-0419435360622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellIPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class

LEPR SVEP1 AOX1

4.67e-04194353da3e1d39575969a069ef43e552afe94b2f441d0b
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC9A9 SVEP1 AOX1

4.67e-0419435389b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellLA-14._Fibroblast_III|World / Chamber and Cluster_Paper

SLC9A9 SVEP1 AOX1

4.67e-04194353803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

SLC9A9 SVEP1 TRPC6

4.67e-04194353a3e5a15cf6c1361207f661ee15eb634f77daf1cb
ToppCellAdult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor

GPAT3 SLC9A9 PLXND1

4.67e-04194353800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SVEP1 TRPC6 AOX1

4.74e-041953534243190ad291d56694e2155954dbaa879c9d3844
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CFAP54 EML6 OR2AG1

4.74e-04195353bb30ac112f8c42d113fa83a9b662e40c0685bb1e
ToppCellAdult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor

GPAT3 SLC9A9 LYST

4.74e-04195353ea24da6fea1487acb1e56c28c0649858cc0a12bd
ToppCellRA-02._Fibroblast_II|RA / Chamber and Cluster_Paper

SLC9A9 SVEP1 AOX1

4.74e-041953536a02ebbeb3199447ddce64d92d8809436e040eba
ToppCellLA-02._Fibroblast_II|World / Chamber and Cluster_Paper

SLC9A9 SVEP1 AOX1

4.74e-04195353a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

SVEP1 TRPC6 AOX1

4.74e-04195353aa0add081881d349099d12efca5cdee098038d4e
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SVEP1 TRPC6 AOX1

4.74e-04195353df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCellILEUM-non-inflamed-(7)_Endothelial_cell-(7)_ACKR1+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

TSPAN6 LYST LEPR

4.88e-04197353143607d195c8aa2b94d995af0b2ef38582565611
ToppCellMonocytes-cDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis

GPAT3 PLXNB2 TRPC6

4.88e-041973533388c104af4c6a05988e102627e0c5e34d9dcc45
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC9A9 SVEP1 TRPC6

4.88e-041973530dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LVRN LEPR AOX1

4.88e-04197353c747c496ac090309b7f8a3e9d840928f12c83f2f
ToppCellnucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SVEP1 TRPC6 AOX1

4.95e-041983538f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCellCOPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class

LEPR SVEP1 AOX1

4.95e-041983532f13c0b3372af53d1bd85f9546f315c878580a71
ToppCellAdult-Mesenchymal|Adult / Lineage, Cell type, age group and donor

SVEP1 TRPC6 AOX1

4.95e-0419835326e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCellCOPD-Stromal-Fibroblast|COPD / Disease state, Lineage and Cell class

LEPR SVEP1 AOX1

4.95e-041983537904af61473cb20064f7a3a1e1bfe8d5913cf317
Diseasespontaneous preterm birth

LVRN KLHL1 SVEP1

2.16e-04101343EFO_0006917
DiseaseKidney Failure

LEPR TRPC6

2.93e-0422342C0035078
Diseaseprimary aldosteronism

KLHL1 EML6

4.12e-0426342MONDO_0001422
Diseasesleep duration

IPO5 SLC9A9 ALG10B TRPC6

7.73e-04362344EFO_0005271
Diseasenon-alcoholic fatty liver disease (implicated_via_orthology)

UBR1 LEPR

7.92e-0436342DOID:0080208 (implicated_via_orthology)
Diseaseosteoarthritis, hand

LVRN CFAP54

8.37e-0437342EFO_1000789
Diseasefibrinogen measurement, tissue plasminogen activator measurement

PLXND1 LEPR

1.24e-0345342EFO_0004623, EFO_0004791
Diseasedevelopmental disorder of mental health (implicated_via_orthology)

PLXND1 PLXNB2

1.46e-0349342DOID:0060037 (implicated_via_orthology)
Diseaseobesity (implicated_via_orthology)

PLXND1 PLXNB2 LEPR

1.93e-03215343DOID:9970 (implicated_via_orthology)
Diseasetransient cerebral ischemia (implicated_via_orthology)

PLXND1 TRPC6

2.48e-0364342DOID:224 (implicated_via_orthology)
Diseasecitrate measurement

FBXO39 PFKFB2

3.76e-0379342EFO_0010114
Diseasehypertension

PLXNB2 TRPC6 EML6

5.26e-03307343EFO_0000537
Diseasemean platelet volume

SLC9A9 PLXND1 LEPR SVEP1 EML6

5.91e-031020345EFO_0004584
Diseaselifestyle measurement, alcohol consumption measurement

SLC9A9 CFAP54

7.79e-03115342EFO_0007878, EFO_0010724

Protein segments in the cluster

PeptideGeneStartEntry
LRMSEKKCSWASYMT

PFKFB2

21

O60825
KALEYLLWASMCMES

CFAP54

266

Q96N23
MANSRFSCTQIWVKM

ARMH2

1

H3BNL8
SMSFKNLSMLFCLTW

ALG10B

241

Q5I7T1
AMSCSKDPWILNRYM

LVRN

861

Q6Q4G3
CWRECMAMSSYSLRK

AOX1

976

Q06278
IFTTCVDTRWRYMLM

KCNJ4

46

P48050
HYSVIMNRSLCLWMA

OR10A7

131

Q8NGE5
LVYCLNRMSMKTSSW

MDN1

2461

Q9NU22
VVERMLSNWMSICLY

PLXNB2

1396

O15031
EKMLTNWMSICMYSC

PLXND1

1491

Q9Y4D7
LHYMTLMSWQTCIRL

OR4K14

131

Q8NGD5
LVCRKWNQMMYSAEL

FBXO39

41

Q8N4B4
YLTKMTCRWSTSTIQ

LEPR

441

P48357
TYMTLMSSRACWLMV

OR2AG1

131

Q9H205
ISYMISAWARMCKIL

IPO5

601

O00410
RWQRSLMSYKSILVM

OBSCN

6746

Q5VST9
SYLLRMMTSWAIVCD

GPAT3

351

Q53EU6
YLLRMMTSWAIVCSV

GPAT4

371

Q86UL3
KNTWNFLKCAYMVMT

EDDM13

116

A0A1B0GTR0
MCRWIYMLSSVFQKQ

LYST

966

Q99698
YKMCWSGMITSLISI

GK5

226

Q6ZS86
WDAMTKHTLSMLRCF

EML6

1446

Q6ZMW3
QKTVSTMYYLWMCST

SCAMP3

161

O14828
SVWSSYRKSCVDMVM

DCAF15

546

Q66K64
NMTKAESARLFRMWY

SLC9A9

516

Q8IVB4
TMTCVAWYINDMKRR

PLEKHG3

261

A1L390
LTCTFWMKSSDDMNY

SVEP1

1451

Q4LDE5
MSAYMLWLNASREKI

SSRP1

551

Q08945
MDCRKMARFSYSVIW

TDGF1

1

P13385
RLGSWMNKIMSYSSD

UBR1

316

Q8IWV7
QARWTLMLLLSTAMY

SLC35A4

16

Q96G79
ATCRASAWMLKLYAM

TSPAN6

81

O43657
MRNKSRWAMYLSSQS

ZGRF1

321

Q86YA3
KQLFRMKTSCFSWME

TRPC6

481

Q9Y210
MDCRKMVRFSYSVIW

TDGF1P3

1

P51864
MWVKYDMQSRCNDLS

KLHL1

381

Q9NR64